Full definition
E-prescribing (electronic prescribing) is the direct electronic transmission of a prescription from the clinician's EMR to the pharmacy. The clinician selects medication, strength, frequency, duration, and dispense quantity from a structured pick-list; the system validates against drug-interaction databases, allergy lists, formularies, and patient-specific contraindications; the prescription is electronically transmitted to the patient's preferred pharmacy.
E-prescribing is mandatory in many jurisdictions (US Medicare, several EU countries, increasingly in Asia). Even where optional, it's now near-universal for most outpatient prescriptions. The clinical-quality case is strong: handwritten errors eliminated, drug-interaction alerts at point of order, formulary compliance, and audit trail. The patient-experience case is strong: prescription is ready when the patient arrives at the pharmacy.
For controlled substances, additional identity verification is required (EPCS in the US, similar regimes elsewhere) — typically multi-factor authentication of the prescribing clinician at the time of order. MOVO-X supports the requirements for jurisdictions where the platform is deployed.
Where e-prescribing is used
- Outpatient clinic prescribing
- Hospital discharge prescriptions
- Telemedicine consultations
- Pharmacy benefit management programmes
- Controlled-substance prescribing (with EPCS)
Types of e-prescribing
Standard e-prescribing
Routine outpatient prescriptions.
EPCS (controlled substances)
Electronic Prescribing of Controlled Substances — requires MFA.
Specialty pharmacy
High-cost specialty drugs (oncology, biologics).
Mail-order e-prescribing
Long-term-care medication delivery.
Quantified benefits
- ▸Handwritten-error elimination
- ▸Drug-interaction and allergy alerts at point of order
- ▸Formulary and benefit-design compliance
- ▸Audit-grade trail of every prescription
Frequently asked
Is e-prescribing required?+
In many jurisdictions, yes — US Medicare mandates e-prescribing for Part D drugs. Several EU countries similarly. Most other markets are voluntary but rapidly approaching universal.
What about controlled substances?+
Additional requirements (EPCS in US, similar elsewhere) — typically MFA on the clinician at the time of order. MOVO-X supports EPCS for US deployments.
Does MOVO-X include e-prescribing?+
Yes — built into the clinical workflow. Integrates with country-specific e-prescribing infrastructure (Surescripts in US, regional networks elsewhere).
What about pharmacy choice?+
Patient selects their pharmacy at the kiosk or in the portal. Prescription routes to that pharmacy.
How does this work in countries without e-prescribing infrastructure?+
MOVO-X supports printed prescriptions (with QR for pharmacy scanning) where electronic transmission isn't available, while contributing to the development of national e-prescribing capability.